Explore how LC-MS technologies are transforming forensic and clinical toxicology by enabling comprehensive compound detection ...

Despite being energy-dense, pecans may support weight management when consumed in moderation. Clinical studies have reported ...

Biosimilars are gaining traction as competitors aim to capture market share from branded biologics such as Humira and ...

The 18-meter walk test (18MWT) effectively evaluates disease severity and predicts clinical outcomes in pulmonary arterial ...

The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung ...

UMeWorld Limited (OTC: UMEWF) today announced the results of a clinical study demonstrating the metabolic benefits of diacylglycerol (DAG) oil, the active ingredient in its functional cooking oil ...

BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company ...

A University of Cincinnati researcher launched an app, called High Enroll, to connect patients to clinical trials. The most common barrier to human subject research is a lack of awareness. Many ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...

Rheumatoid arthritis prevention in patients at the subclinical or pre-clinical stage remains challenging, according to a ...

Belgium’s breast cancer patients are often left without reimbursed treatments, exposing a growing gap between precision oncology's promise and policy reality.

Preclinical data supports the advancement of oral Ketamir-2 as a safe, next-generation alternative to ketamine, with ongoing momentum in Phase I clinical trial enrollment ...